NORMAN SOWELL: Open Payments
NPI 1649959941 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,172 in 160 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,466 · 2025 $2,172
Food & beverage: $2,062Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 25 | $367 |
| E.R. Squibb & Sons, L.L.C. | 23 | $293 |
| Alkermes, Inc. | 19 | $253 |
| Lundbeck LLC | 17 | $249 |
| ABBVIE INC. | 19 | $212 |
| Otsuka America Pharmaceutical, Inc. | 18 | $189 |
| Vanda Pharmaceuticals Inc. | 13 | $168 |
| Indivior Inc. | 10 | $136 |
| Corium, LLC | 4 | $48 |
| Janssen Pharmaceuticals, Inc | 3 | $45 |
Products named: COBENFY, ABILIFY ASIMTUFII, UZEDY, VRAYLAR, REXULTI, FANAPT, ARISTADA, SUBLOCADE.
Industry payments across TX — which companies pay providers there.
